GSK plans to test its malaria vaccine in children with HIV
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline is planning a new trial with its RTS,S vaccine, the most clinically advanced malaria vaccine to date, in some 200 African children that are also infected with HIV, the company has told Scrip.